Current Neuro-Oncology

Volume 4 Number 9
30 September 2002

Home > Publications > Current Neuro-Oncology > Volume 4, Year 2002 > Number 9, 30 September


Baker MJ, Brem S, Daniels S, Sherman B, Phuphanich S.
Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate.
J Neurooncol. 2002 Sep;59(3):239-42. doi: 10.1023/a:1019905127442. PMID: 12241121. Case report.

Kristof RA, Neuloh G, Hans V, Deckert M, Urbach H, Schlegel U, Simon M, Schramm J.
Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III.
J Neurooncol. 2002 Sep;59(3):231-7. doi: 10.1023/a:1019987116596. PMID: 12241120. Observational study.

Peretti-Viton P, Brunel H, Chinot O, Daniel C, Barrié M, Bouvier C, Figarella-Branger D, Fuentes S, Dufour H, Grisoli F.
Histological and MR correlations in Gliomatosis cerebri.
J Neurooncol. 2002 Sep;59(3):249-59. doi: 10.1023/a:1019934901750. PMID: 12241123. Observational study.

Wick W, Hermisson M, Kortmann RD, Küker WM, Duffner F, Dichgans J, Bamberg M, Weller M.
Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study.
J Neurooncol. 2002 Sep;59(2):151-5. doi: 10.1023/a:1019641314661. PMID: 12241108. Interventional study.

MacKillop LH, O'Donnell J, Ayliffe W, Jayawardene SA.
Never forget the risks of immunosuppression.
Int J Clin Pract. 2002 Sep;56(7):554-5
. doi: 10.1111/j.1742-1241.2002.tb11319.x. PMID: 12296622. Case report˰ ˍ

O'Neill BP, Blondal H, Yang P, Olafsdottir GH, Sigvaldason H, Jenkins RB, Kimmel DW, Scheithauer BW, Rocca WA, Bjornsson J, Tulinius H.
Risk of cancer among relatives of patients with glioma.
Cancer Epidemiol Biomarkers Prev. 2002
Sep 1;11(9):921-4. PMID: 12223439. Observational study. ˍ

Hargrave DR, Bouffet E, Gammon J, Tariq N, Grant RM, Baruchel S.
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
Cancer. 2002 Sep 5;95(6):1294-301. doi: 10.1002/cncr.10814. PMID: 12216098. Interventional study.

Gutmann DH, Rasmussen SA, Wolkenstein P, MacCollin MM, Guha A, Inskip PD, North KN, Poyhonen M, Birch PH, Friedman JM.
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1).
Neurology. 2002 Sep 10;59(5):759-61. doi: 10.1212/wnl.59.5.759. PMID: 12221173. Observational study.

Bacon CL, Gallagher HC, Haughey JC, Regan CM.
Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase.
J Neurochem. 2002 Sep 18;83(1):12-9. doi: 10.1046/j.1471-4159.2002.01081.x. PMID: 12358724. Laboratory investigation. ˍ


Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA.
How often are nonenhancing supratentorial gliomas malignant? A population study.
Neurology. 2002 Sep 24;59(6):947-9. doi: 10.1212/wnl.59.6.947. PMID: 12297589. Observational study.

Gumprecht H, Ebel GK, Auer DP, Lumenta CB.
Neuronavigation and functional MRI for surgery in patients with lesion in eloquent brain areas.
Minim Invasive Neurosurg. 2002 Sep 26;45(3):151-3. doi: 10.1055/s-2002-34341. PMID: 12353162. Observational study.